Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Open in API
Filings indexed 951 across all filing types
Latest filing 2010-01-07 Director's Dealing
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
MAIN DOCUMENT DESCRIPTION
Director's Dealing
2010-01-07 English
MAIN DOCUMENT DESCRIPTION
Director's Dealing
2010-01-07 English
MAIN DOCUMENT DESCRIPTION
Director's Dealing
2010-01-07 English
FORM S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used for registering securities to be offered under employee benefit plans such as stock incentive plans. It includes detailed information about the stock incentive plan, registration fee calculations, incorporation by reference of other filings (like 10-K and 10-Q), indemnification provisions, and signatures. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration under the Securities Act of 1933. Therefore, it fits the category of Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a report publication announcement but a full registration statement filing.
2009-12-23 English
MAIN DOCUMENT DESCRIPTION
Director's Dealing
2009-12-09 English
424B5
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus supplement filed pursuant to Rule 424(b)(5) related to a securities offering. It includes information about the offering of common stock, risk factors, company background, use of proceeds, and regulatory considerations. The document is not a financial report, earnings release, or management discussion but rather a capital raising disclosure document. It specifically relates to the issuance of shares upon exercise of warrants and provides detailed offering terms and risk disclosures. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and financing activities.
2009-12-08 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.